Click to Share
 
 
  1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Journalist Account
  7. PRNewswire Distribution

cnpr Press Releases

  + XML/RSS  



By NAPSRx
According to a new study published in the journal Neuropharmacology conducted by research academics at Lancaster University, certain type 2 diabetes drugs on the market have produced neuroprotective effects in a mouse model of Alzheimer's disease.

By NAPSRx
The new collaborative effort to develop a single tablet for HIV treatment by industry leaders J &J and Glaxo (Viiv Healthcare) could significantly improve the lives of HIV patients, if successful.

By NAPSRx
A study by Belgian doctoral researcher Wouter De Haes (KU Leuven) and colleagues provides new evidence that metformin, the world's most widely used anti-diabetic drug, slows ageing and increases lifespan.

By NAPSRx
After the markets closed Friday, Amgen and AstraZeneca announced that their top psoriasis contender, brodalumab, scored a win in Phase III, with a large majority of patients in both dosage arms clearing the bar on a standard measure for efficacy.

By NAMSR
Apple is building a team of senior medical technology executives, raising hackles in the biotechnology community and offering a hint of what the iPhone maker may be planning for its widely expected iWatch and other wearable technology.

By NAPSRx
Sales of the Bayer Group advanced by 2.8% in the first quarter of 2014 to $15 million and business expanded by 8.4%. EBIT rose by 18.4% to $3 million after net special items of plus $9.7 million.

By NAPSRx
Novartis has won early FDA approval for their new drug; Zykadia.

By NAPSRx
Novartis announced that it had reached definitive agreements with GlaxoSmithKline plc (GSK) and Eli Lilly and Company (Lilly) on a set of transactions.

By NAPSRx
U.S. drugmaker AbbVie Inc reported better-than-expected quarterly sales and earnings, fueled by a sizzling performance from its Humira treatment for rheumatoid arthritis, the world's top-selling prescription medicine.

By NAPSRx
A team of researchers from Columbia University Medical Center (CUMC), Weill Cornell Medical College, and Brandeis University has devised a wholly new approach to the treatment of Alzheimer's disease involving the so-called retromer protein complex.

By NAPSRx
Pfizer Inc. (PFE), the world’s biggest drugmaker, held informal, now-discontinued talks with AstraZeneca Plc about possibly buying the London-based maker of asthma and heart drugs, said two people familiar with the matter.

By NAPSRx
GlaxoSmithKline (GSK) has received approval from the US Food and Drug Administration (FDA) for its Tanzeum (albiglutide) subcutaneous injection to improve glycemic control, along with diet and exercise, in adult patients with type 2 diabetes.

By NAPSRx
A sharp drop in the number of young women infected with the two strains of human papillomavirus (HPV) most likely to cause cervical cancer occurred in England after the 2008 launch of a national vaccination program there, a new study shows.

By NAPSRx
Plans for a new type of DNA vaccine to protect against the deadly HIV and Hepatitis C viruses have taken an important step forward, with University of Adelaide researchers applying for a patent based on groundbreaking new research.

By NAPSRx
GSK and J&J have released a new AIDS drug to transform the outlook of the disease. New pharmaceutical candidates will be needed for proper promotion of these products to various markets.

By NAPSR
Researchers at the University of Illinois at Chicago have developed a system for precisely delivering anti-inflammatory drugs to immune cells gone out of control, while sparing their well-behaved counterparts.

By NAPSR
According to the Centers for Disease Control, more than two million people come down with antibiotic-resistant infections annually, and at least 23,000 die because their treatment can't stop the infection. In addition, the pipeline for new antibiotic

By NAPSR
Artificial bone marrow may be used to reproduce hematopoietic stem cells. A prototype has now been developed by scientists of KIT, the Max Planck Institute for Intelligent Systems, Stuttgart, and Tübingen University (Germany).

By NAPSR
Pfizer Inc. reported financial results for third-quarter 2013. Reported revenues decreased $310 million, or 2%, which reflects an operational decline of $38 million, or less than 1%, and the unfavorable impact of foreign exchange of $272 m

By NAPSR
University of Miami Miller School of Medicine researchers played a key role in the largest international Alzheimer's disease genetics collaboration, which identified 11 new regions of the genome that contribute to late-onset Alzheimer's disease.

All Press Releases

By NAPSRx
Incyte Corporation has received approval for Jakafi® (ruxolitinib), the first and only FDA-approved oral medication for patients with polycythemia vera (PV) who have had an inadequate response to or are intolerant of hydroxyurea.

By NAPSRx
According to a new study published in the journal Neuropharmacology conducted by research academics at Lancaster University, certain type 2 diabetes drugs on the market have produced neuroprotective effects in a mouse model of Alzheimer's disease.

By NAPSRx
With the USA accounting for 34% of the world's pharmaceuticals, representatives are needed to promote new products coming down the pipeline. Meet job requirements with the NAPSRx's pharmaceutical sales training.

By NAPSRx
Pharmaceutical Sales is one of the highest paid professions in sales and earnings are expected to increase in the coming years. Now is the time to get into this amazing field.

By NAPSRx
The new collaborative effort to develop a single tablet for HIV treatment by industry leaders J &J and Glaxo (Viiv Healthcare) could significantly improve the lives of HIV patients, if successful.

By NAPSRx
A study by Belgian doctoral researcher Wouter De Haes (KU Leuven) and colleagues provides new evidence that metformin, the world's most widely used anti-diabetic drug, slows ageing and increases lifespan.

By NAPSRx
Eli Lilly and Co. said its Type II diabetes drug was more effective than Sanofi SA's approved drug Lantus in reducing patients' blood sugar levels in 3 late-stage trials.

By NAPSRx
After the markets closed Friday, Amgen and AstraZeneca announced that their top psoriasis contender, brodalumab, scored a win in Phase III, with a large majority of patients in both dosage arms clearing the bar on a standard measure for efficacy.

By NAMSR
Apple is building a team of senior medical technology executives, raising hackles in the biotechnology community and offering a hint of what the iPhone maker may be planning for its widely expected iWatch and other wearable technology.

By NAPSRx
Sales of the Bayer Group advanced by 2.8% in the first quarter of 2014 to $15 million and business expanded by 8.4%. EBIT rose by 18.4% to $3 million after net special items of plus $9.7 million.

By NAPSRx
In the latest deal in the pharmaceutical space, Germany-based Bayer is acquiring Merck's consumer care business, which includes well-known brands like Claritin, Afrin and Coppertone, for $14.2 billion.

By NAPSRx
The roll-out of Novo Nordisk's ultra-long-acting insulin Tresiba is off to an encouraging start, picking up sales of around $15 million USD in the first quarter of the year.

By NAPSRx
Novartis has won early FDA approval for their new drug; Zykadia.

By NAPSRx
Actavis plc’s first quarter 2014 earnings came in at $3.49 per share, well above the Zacks Consensus Estimate of $3.29 per share and 75.4% above the year-ago earnings.

By NAPSRx
Novartis announced that it had reached definitive agreements with GlaxoSmithKline plc (GSK) and Eli Lilly and Company (Lilly) on a set of transactions.

By NAPSRx
U.S. drugmaker AbbVie Inc reported better-than-expected quarterly sales and earnings, fueled by a sizzling performance from its Humira treatment for rheumatoid arthritis, the world's top-selling prescription medicine.

By NAPSRx
Ritalin, a drug used to treat attention-deficit/hyperactivity disorder, may help people maintain self-control so they can stick to a diet or a boring project, a new study suggests.

By NAPSRx
A team of researchers from Columbia University Medical Center (CUMC), Weill Cornell Medical College, and Brandeis University has devised a wholly new approach to the treatment of Alzheimer's disease involving the so-called retromer protein complex.

By NAPSRx
Novartis and GSK to join forces in consumer healthcare, while Pfizer thought to be considering a $100bn bid for AstraZeneca

By NAPSRx
Pfizer Inc. (PFE), the world’s biggest drugmaker, held informal, now-discontinued talks with AstraZeneca Plc about possibly buying the London-based maker of asthma and heart drugs, said two people familiar with the matter.

By NAPSRx
The firm's consumer and medical-device group are lagging, but strong results from the pharmaceuticals side should drive earnings throughout this year and into 2015, says Morningstar's Damien Conover.

By NAPSRx
GlaxoSmithKline (GSK) has received approval from the US Food and Drug Administration (FDA) for its Tanzeum (albiglutide) subcutaneous injection to improve glycemic control, along with diet and exercise, in adult patients with type 2 diabetes.

By NAPSRx
A sharp drop in the number of young women infected with the two strains of human papillomavirus (HPV) most likely to cause cervical cancer occurred in England after the 2008 launch of a national vaccination program there, a new study shows.

By NAPSRx
Merck Serono, the biopharmaceutical division of Merck, announced that its U.S. affiliate EMD Serono has signed a research agreement with Pfizer Inc. and the Broad Institute in Cambridge, Massachusetts, U.S.

By NAPSRx
Plans for a new type of DNA vaccine to protect against the deadly HIV and Hepatitis C viruses have taken an important step forward, with University of Adelaide researchers applying for a patent based on groundbreaking new research.

By NAPSRx
The need for fresh pharmaceutical sales representatives will increase, along with the increase in sales growth for new pharmaceuticals that are in the market.

By NAPSRx
GSK and J&J have released a new AIDS drug to transform the outlook of the disease. New pharmaceutical candidates will be needed for proper promotion of these products to various markets.

By NAPSR
Researchers at the University of Illinois at Chicago have developed a system for precisely delivering anti-inflammatory drugs to immune cells gone out of control, while sparing their well-behaved counterparts.

By NAPSR
According to the Centers for Disease Control, more than two million people come down with antibiotic-resistant infections annually, and at least 23,000 die because their treatment can't stop the infection. In addition, the pipeline for new antibiotic

By NAPSR
Artificial bone marrow may be used to reproduce hematopoietic stem cells. A prototype has now been developed by scientists of KIT, the Max Planck Institute for Intelligent Systems, Stuttgart, and Tübingen University (Germany).

By NAPSR
Pfizer Inc. has entered into an agreement with GSK to explore the anti-cancer efficacy and the safety of GSK's trametinib combined with Pfizer's palbociclib (PD-0332991) in a Phase I/II study in patients with advanced/metastatic melanoma.

By NAPSR
A study published in the journal Nature Medicine suggests a potential new treatment for the seizures that often plague children with genetic metabolic disorders and individuals undergoing liver failure.

By NAPSRx
The most frequently mutated gene across all types of cancers is a gene called p53. Unfortunately it has been difficult to directly target this gene with drugs. Now a multi-institutional research team has identified a family of enzymes.

By NAPSR
The Bayer Group continued its positive business momentum in the third quarter of 2013, with substantial contributions from the Life Science businesses HealthCare and CropScience

By NAPSR
A team of 22 scientists from 11 research institutes led by Professor Bazbek Davletov, now at the University of Sheffield, created and characterised a new molecule that was able to alleviate hypersensitivity to inflammatory pain.

By NAPSR
Pfizer Inc. reported financial results for third-quarter 2013. Reported revenues decreased $310 million, or 2%, which reflects an operational decline of $38 million, or less than 1%, and the unfavorable impact of foreign exchange of $272 m

By NAPSR
An international team led by University of Adelaide researchers has identified the mechanism of pain relief of a new drug for treating Irritable Bowel Syndrome with Constipation (IBS-C)

By NAPSR
A new review suggests that omega-3 fatty acids taken in excess could have unintended health consequences in certain situations, and that dietary standards based on the best available evidence need to be established.

By NAPSR
University of Miami Miller School of Medicine researchers played a key role in the largest international Alzheimer's disease genetics collaboration, which identified 11 new regions of the genome that contribute to late-onset Alzheimer's disease.

By NAPSR
Bristol-Myers Squibb Company (NYSE:BMY) has reported results for the third quarter of 2013 highlighted by the strong performance of key marketed products such as Yervoy, Orencia and Sprycel.

By NAPSR
In a feat of modern-day alchemy with huge potential for regenerative medicine, Stanford University School of Medicine scientists have developed a fast, efficient way to turn cells extracted from routine liposuction into liver cells.

By NAPSR
Biotech drugmaker Amgen Inc. said Tuesday that its third-quarter profit jumped 24 percent, trouncing analysts' expectations, as sales of more than a half-dozen of its drugs increased by double digits, one of them helped by a big government purchase.

By NAPSR
The investigational drug AZD9291, a third-generation EGFR inhibitor, showed promise in preclinical studies and provides hope for patients with advanced lung cancers that have become resistant to existing EGFR inhibitors.

By NAPSRx
Group sales rose 6% to 34.9 billion Swiss francs in the first nine months of the year due to strong demand for Roche's HER2 breast-cancer treatments. Now is the time to enter this wonderful field of pharmaceutical sales.

By NAPSR
Parvoviruses cause no harm in humans, but they can kill cancer cells. Scientists at the German Cancer Research Center have been studying these viruses with the aim of developing a viral therapy to treat a type of aggressively growing brain cancer.

By NAPSR
Scientists have combined cutting edge computer modelling with pharmacology and medicinal chemistry to reveal new insights into how the body interacts with novel drug treatments.

By NAPSR
Abbott today announced financial results for the third quarter ended Sept. 30, 2013. Third-quarter 2013 worldwide sales of $5.4 billion increased 4.3 percent on an operational basis, with strong performance in Diagnostics and Medical Devices.

By NAPSR
A recent study by a University of Missouri researcher shows that resveratrol, a compound found in grape skins and red wine, can make certain tumor cells more susceptible to radiation treatment.

By NAPSRx
A new method for creating stem cells for the human liver and pancreas, which could enable both cell types to be grown in sufficient quantities for clinical use, has been developed by scientists.

By NAPSR
Early treatment of heart attack patients with an inexpensive beta-blocker drug called metoprolol, can significantly reduce damage to the heart during a myocardial infarction.



Page:

Page updated every 10 minutes


  1. SiteMap
  2. Contact PRLog
  3. Privacy Policy
  4. Terms of Service
  5. Copyright Notice
  6. About
  7. Advertise
Like PRLog?
9K2K1K
Click to Share